...
首页> 外文期刊>Digital Health >Multifactorial e- and mHealth interventions for cardiovascular disease primary prevention: Protocol for a systematic review and meta-analysis of randomised controlled trials
【24h】

Multifactorial e- and mHealth interventions for cardiovascular disease primary prevention: Protocol for a systematic review and meta-analysis of randomised controlled trials

机译:用于心血管疾病的多因素和MHealth干预初步:随机对照试验的系统审查和荟萃分析的议定书

获取原文
           

摘要

Objective Cardiovascular diseases (CVD) are a leading cause of mortality and disease burden. Preventative interventions to augment the population-level adoption of health lifestyle behaviours that reduce CVD risk are a priority. Face-to-face interventions afford individualisation and are effective for improving health-related behaviours and outcomes, but they are costly and resource intensive. Electronic and mobile health (e- and mHealth) approaches aimed at modifying lifestyle risk factors may be an effective and scalable approach to reach many individuals while preserving individualisation. This systematic review aims to (a) determine the effectiveness of multifactorial e- and mHealth interventions on CVD risk and on lifestyle-related cardiometabolic risk factors and self-management behaviours among adults without CVD; and (b) describe the evidence on adverse events and on the cost-effectiveness of these interventions. Methods Methods were detailed prior to the start of the review in order to improve conduct and prevent inconsistent decision making throughout the review. This protocol was prepared following the PRISMA-P 2015 statement. MEDLINE, CINAHL, Embase, PsycINFO, Web of Science, Cochrane Public Health Group Specialised Register and CENTRAL electronic databases will be searched between 1991 and September 2019. Eligibility criteria are: (a) population: community-dwelling adults; (b) intervention/comparison: randomised controlled trials comparing e- or mHealth CVD risk preventative interventions with usual care; and (c) outcomes: modifiable CVD risk factors. Selection of study reports will involve two authors independently screening titles and abstracts, followed by a full-text review of potentially eligible reports. Two authors will independently undertake data extraction and assess risk of bias. Where appropriate, meta-analysis of outcome data will be performed. Discussion This protocol describes the pre-specified methods for a systematic review that will provide quantitative and narrative syntheses of current multifactorial e- and mHealth CVD preventative interventions. A systematic review and meta-analysis will be conducted following the methods outlined in the Cochrane Handbook for Systematic Reviews of Interventions and reported according to PRISMA guidelines.
机译:客观的心血管疾病(CVD)是死亡率和疾病负担的主要原因。预防性干预措施增加了减少CVD风险的卫生生活方式行为的人口层面是优先事项。面对面的干预措施提供个性化,并且有效地改善与健康有关的行为和结果,但它们是昂贵和资源密集的。旨在改变生活方式风险因素的电子和移动健康(E-和MHEALTH)方法可能是一种有效且可扩展的方法,可以在保存个性的同时到达许多人。该系统审查旨在(a)确定多因素和MHEALTES关于CVD风险的有效性以及没有CVD的成年人中的生活方式相关的心脏异常风险因素和自我管理行为; (b)描述了对不良事件的证据和这些干预措施的成本效益。方法在审查开始之前详细说明方法,以便在整个审查中改进行为和防止不一致的决策。在Prisma-P 2015陈述之后制备该方案。 Medline,Cinahl,Embase,Psycinfo,科学网,Cochrane公共卫生小组专业登记册和中央电子数据库将在2019年至2019年至9月期间进行搜查。资格标准是:(a)人口:社区住宅; (b)干预/比较:随机对照试验比较E-或MHECHT CVD风险预防性干预措施与普通护理; (c)结果:可修改的CVD风险因素。学习报告的选择将涉及两位作者独立筛查标题和摘要,然后是潜在符合条件的报告的全文审查。两位作者将独立进行数据提取和评估偏见的风险。在适当的情况下,将执行结果数据的元分析。讨论本协议描述了系统审查的预先指定的方法,该方法将提供当前多因素和MHECHEAL CVD预防性干预措施的定量和叙事合成。将在Cochrane手册中概述的方法进行系统审查和荟萃分析,以进行干预措施的系统性审查,并根据PRISMA准则报告。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号